Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432

Project will be a demonstration of how Ubiquigent’s DUB-centric platform can support the development of DUB inhibitors all the way from discovery through to clinical development.

Medtronic expands AI endoscopy partnership with Cosmo

Dive Brief: Medtronic will pay Cosmo Intelligent Medical Devices $100 million upfront to expand a partnership that makes Medtronic the exclusive global distributor of Cosmo’s GI

December 11, 2023

BMI not a complete measure of metabolic health, research shows

Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity,

June 15, 2023

Illumina’s ‘inevitable’ split from Grail likely by mid-2024, analysts say

Dive Brief: The European Commission is “almost certain” to force Illumina’s divestment of Grail, a move that could happen in the first half of 2024, analysts

July 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.